
NMLSF
Healthcare · Biotechnology · $4.0M market cap
$0.0633+0.05 (+313.7%)Nov 13, 9:30 AM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 27, 2025 | After the close | — | -0.02 | — |
| Nov 27, 2024 | After the close | — | 0.01 | — |
| Aug 26, 2024 | After the close | — | -0.00 | — |
| May 29, 2024 | After the close | — | -0.00 | — |
| Dec 28, 2023 | After the close | — | -0.00 | — |
| Aug 29, 2023 | After the close | — | -0.00 | — |
| May 30, 2023 | After the close | — | -0.00 | — |
Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company in Canada. It engages in research and development of psilocybin; and fund food-related research initiative in support of its expanding portfolio of consumer health and wellness products. The company has collaboration with the University of Manitoba's Richardson Centre for food technology and research (RCFTR) to support a…